BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 27377897)

  • 21. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease.
    Solomon RJ; Natarajan MK; Doucet S; Sharma SK; Staniloae CS; Katholi RE; Gelormini JL; Labinaz M; Moreyra AE;
    Circulation; 2007 Jun; 115(25):3189-96. PubMed ID: 17562951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Intravenous Administration of Contrast Media on Serum Creatinine Levels in Neonates.
    Bedoya MA; White AM; Edgar JC; Pradhan M; Raab EL; Meyer JS
    Radiology; 2017 Aug; 284(2):530-540. PubMed ID: 28387639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low incidence of nephrotoxicity following intravenous administration of iodinated contrast media: a prospective study.
    Castaldo P; Frascà GM; Brigante F; Ferrante L; Magi S; Pavani M; Skrami E; Giuseppetti GM; Polonara G; Amoroso S
    Eur Radiol; 2019 Jul; 29(7):3927-3934. PubMed ID: 30989349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors and Outcomes of Postcontrast Acute Kidney Injury after Endovascular Renal Artery Intervention.
    Takahashi EA; Kallmes DF; Fleming CJ; McDonald RJ; McKusick MA; Bjarnason H; Harmsen WS; Misra S
    J Vasc Interv Radiol; 2017 Dec; 28(12):1687-1692. PubMed ID: 28947366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).
    Bolognese L; Falsini G; Schwenke C; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
    Am J Cardiol; 2012 Jan; 109(1):67-74. PubMed ID: 21943940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contrast medium-induced acute kidney injury: comparison of intravenous and intraarterial administration of iodinated contrast medium.
    Karlsberg RP; Dohad SY; Sheng R;
    J Vasc Interv Radiol; 2011 Aug; 22(8):1159-65. PubMed ID: 21570871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of Acute Kidney Injury Following Contrast-enhanced CT in Hospitalized Pediatric Patients: A Propensity Score Analysis.
    Gilligan LA; Davenport MS; Trout AT; Su W; Zhang B; Goldstein SL; Dillman JR
    Radiology; 2020 Mar; 294(3):548-556. PubMed ID: 31961262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No Association between Intravenous Contrast Material Exposure and Adverse Clinical Outcome: Are Prevention Protocols Effective?
    Gramberg MC; Penne EL
    Radiology; 2015 Oct; 277(1):306. PubMed ID: 26402500
    [No Abstract]   [Full Text] [Related]  

  • 29. Response.
    McDonald RJ; McDonald JS; Carter RE; Hartman RP; Katzberg RW; Kallmes DF; Williamson EE
    Radiology; 2015 Oct; 277(1):306-7. PubMed ID: 26668855
    [No Abstract]   [Full Text] [Related]  

  • 30. Response.
    McDonald RJ; McDonald JS; Carter RE; Hartman RP; Katzberg RW; Kallmes DF; Williamson EE
    Radiology; 2015 Jun; 275(3):931-2. PubMed ID: 26199958
    [No Abstract]   [Full Text] [Related]  

  • 31. Is the risk of contrast-induced nephropathy a real contraindication to perform intravenous contrast enhanced Computed Tomography for non-traumatic acute abdomen in Emergency Surgery Department?
    De Simone B; Ansaloni L; Sartelli M; Gaiani F; Leandro G; De' Angelis GL; Di Mario F; Coccolini F; Catena F
    Acta Biomed; 2018 Dec; 89(9-S):158-172. PubMed ID: 30561410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine.
    Briguori C; Colombo A; Airoldi F; Morici N; Sangiorgi GM; Violante A; Focaccio A; Montorfano M; Carlino M; Condorelli G; Ricciardelli B
    Kidney Int; 2005 Nov; 68(5):2250-5. PubMed ID: 16221226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-contrast acute kidney injury in intensive care unit patients: a propensity score-adjusted study.
    McDonald JS; McDonald RJ; Williamson EE; Kallmes DF; Kashani K
    Intensive Care Med; 2017 Jun; 43(6):774-784. PubMed ID: 28213620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety.
    Lenhard DC; Pietsch H; Sieber MA; Ernst R; Lengsfeld P; Ellinghaus P; Jost G
    Invest Radiol; 2012 Sep; 47(9):503-10. PubMed ID: 22864374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of contrast-induced nephropathy in kidney transplant recipients.
    Haider M; Yessayan L; Venkat KK; Goggins M; Patel A; Karthikeyan V
    Transplant Proc; 2015 Mar; 47(2):379-83. PubMed ID: 25769577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minimal risk of contrast-induced kidney injury in a randomly selected cohort with mildly reduced GFR.
    Carlqvist J; Nyman U; Sterner G; Brandberg J; Fagman E; Hellström M
    Eur Radiol; 2021 May; 31(5):3248-3257. PubMed ID: 33155105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of contrast-induced acute kidney injury in a large cohort of all-comers undergoing percutaneous coronary intervention: Comparison of five contrast media.
    Azzalini L; Vilca LM; Lombardo F; Poletti E; Laricchia A; Beneduce A; Maccagni D; Demir OM; Slavich M; Giannini F; Carlino M; Margonato A; Cappelletti A; Colombo A
    Int J Cardiol; 2018 Dec; 273():69-73. PubMed ID: 30196995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute Kidney Injury After Intravenous Versus Intra-Arterial Contrast Material Administration in a Paired Cohort.
    McDonald JS; Leake CB; McDonald RJ; Gulati R; Katzberg RW; Williamson EE; Kallmes DF
    Invest Radiol; 2016 Dec; 51(12):804-809. PubMed ID: 27299579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Negative effects of iodine-based contrast agent on renal function in patients with moderate reduced renal function hospitalized for COVID-19.
    Kistner A; Tamm C; Svensson AM; Beckman MO; Strand F; Sköld M; Nyrén S
    BMC Nephrol; 2021 Aug; 22(1):297. PubMed ID: 34465289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
    Nie B; Cheng WJ; Li YF; Cao Z; Yang Q; Zhao YX; Guo YH; Zhou YJ
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):958-65. PubMed ID: 19021282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.